EcoDrugPlus

Ribosomal Protein S4 X-Linked

Ensembl ID : ENSLCAG00010024234
Gene Symbol: LOC108902092
4 Cross references
494 Possible Orthologues:

Ribosomal Protein S5

Ensembl ID : ENSLCAG00010015426
Gene Symbol: LOC108890316
4 Cross references
264 Possible Orthologues:

Ribosomal Protein S6 Kinase B1

Ensembl ID : ENSLCAG00010016516
Gene Symbol: RPS6KB1
4 Cross references
158 Possible Orthologues:

Ribosomal Protein S9

Ensembl ID : ENSLCAG00010009141
Gene Symbol: LOC108887278
4 Cross references
235 Possible Orthologues:

Ribosomal Protein Sa

Ensembl ID : ENSLCAG00010019953
Gene Symbol: LOC108898626
4 Cross references
515 Possible Orthologues:

Ribosomal Protein, Large, P1

Ensembl ID : ENSLCAG00010012922
Gene Symbol: LOC108898211
4 Cross references
377 Possible Orthologues:

Selectin E

Ensembl ID : ENSLCAG00010011774
Gene Symbol: SELE
4 Cross references
182 Possible Orthologues:

Selectin P

Ensembl ID : ENSLCAG00010011764
Gene Symbol: SELP
4 Cross references
49 Possible Orthologues:

Serine/threonine-Protein Kinase Pim-3

Ensembl ID : ENSLCAG00010023681
Gene Symbol: LOC108899862
4 Cross references
172 Possible Orthologues:

Si:dkey-211g8.6

Ensembl ID : ENSLCAG00010015912
Gene Symbol: SI:DKEY-211G8.6
1 Cross references
320 Possible Orthologues:

Sigma Non-Opioid Intracellular Receptor 1

Ensembl ID : ENSLCAG00010003870
Gene Symbol: LOC108880305
4 Cross references
204 Possible Orthologues:

Smoothened, Frizzled Class Receptor

Ensembl ID : ENSLCAG00010022379
Gene Symbol: LOC108879629
4 Cross references
204 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).